CVS HEALTH CORP (1CVS.MI) Fundamental Analysis & Valuation

BIT:1CVS • US1266501006

Current stock price

67.5 EUR
+0.45 (+0.67%)
Last:

This 1CVS.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. 1CVS.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1CVS was profitable.
  • 1CVS had a positive operating cash flow in the past year.
  • 1CVS had positive earnings in each of the past 5 years.
  • Each year in the past 5 years 1CVS had a positive operating cash flow.
1CVS.MI Yearly Net Income VS EBIT VS OCF VS FCF1CVS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B

1.2 Ratios

  • 1CVS has a worse Return On Assets (0.70%) than 73.33% of its industry peers.
  • The Return On Equity of 1CVS (2.35%) is worse than 70.00% of its industry peers.
  • 1CVS's Return On Invested Capital of 4.90% is on the low side compared to the rest of the industry. 1CVS is outperformed by 63.33% of its industry peers.
  • 1CVS had an Average Return On Invested Capital over the past 3 years of 5.46%. This is in line with the industry average of 5.73%.
Industry RankSector Rank
ROA 0.7%
ROE 2.35%
ROIC 4.9%
ROA(3y)1.95%
ROA(5y)2.24%
ROE(3y)6.46%
ROE(5y)7.21%
ROIC(3y)5.46%
ROIC(5y)6.31%
1CVS.MI Yearly ROA, ROE, ROIC1CVS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

1.3 Margins

  • 1CVS's Profit Margin of 0.44% is on the low side compared to the rest of the industry. 1CVS is outperformed by 73.33% of its industry peers.
  • 1CVS's Profit Margin has declined in the last couple of years.
  • 1CVS's Operating Margin of 2.58% is on the low side compared to the rest of the industry. 1CVS is outperformed by 70.00% of its industry peers.
  • 1CVS's Operating Margin has declined in the last couple of years.
  • 1CVS has a worse Gross Margin (13.77%) than 66.67% of its industry peers.
  • 1CVS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.58%
PM (TTM) 0.44%
GM 13.77%
OM growth 3Y-19.74%
OM growth 5Y-12.87%
PM growth 3Y-30.97%
PM growth 5Y-30.29%
GM growth 3Y-6.6%
GM growth 5Y-5.48%
1CVS.MI Yearly Profit, Operating, Gross Margins1CVS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

3

2. 1CVS.MI Health Analysis

2.1 Basic Checks

  • 1CVS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • 1CVS has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for 1CVS has been reduced compared to 5 years ago.
  • Compared to 1 year ago, 1CVS has an improved debt to assets ratio.
1CVS.MI Yearly Shares Outstanding1CVS.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
1CVS.MI Yearly Total Debt VS Total Assets1CVS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B 200B 250B

2.2 Solvency

  • 1CVS has an Altman-Z score of 2.34. This is not the best score and indicates that 1CVS is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.34, 1CVS is doing good in the industry, outperforming 73.33% of the companies in the same industry.
  • 1CVS has a debt to FCF ratio of 8.27. This is a slightly negative value and a sign of low solvency as 1CVS would need 8.27 years to pay back of all of its debts.
  • 1CVS has a Debt to FCF ratio of 8.27. This is comparable to the rest of the industry: 1CVS outperforms 53.33% of its industry peers.
  • 1CVS has a Debt/Equity ratio of 0.80. This is a neutral value indicating 1CVS is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.80, 1CVS is in line with its industry, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 8.27
Altman-Z 2.34
ROIC/WACC0.61
WACC8%
1CVS.MI Yearly LT Debt VS Equity VS FCF1CVS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • 1CVS has a Current Ratio of 0.84. This is a bad value and indicates that 1CVS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • 1CVS has a Current ratio (0.84) which is in line with its industry peers.
  • A Quick Ratio of 0.63 indicates that 1CVS may have some problems paying its short term obligations.
  • 1CVS's Quick ratio of 0.63 is in line compared to the rest of the industry. 1CVS outperforms 43.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.63
1CVS.MI Yearly Current Assets VS Current Liabilites1CVS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

5

3. 1CVS.MI Growth Analysis

3.1 Past

  • 1CVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.54%, which is quite impressive.
  • Measured over the past years, 1CVS shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.11% on average per year.
  • Looking at the last year, 1CVS shows a small growth in Revenue. The Revenue has grown by 7.85% in the last year.
  • The Revenue has been growing by 8.39% on average over the past years. This is quite good.
EPS 1Y (TTM)24.54%
EPS 3Y-8.11%
EPS 5Y-2.11%
EPS Q2Q%-8.4%
Revenue 1Y (TTM)7.85%
Revenue growth 3Y7.63%
Revenue growth 5Y8.39%
Sales Q2Q%8.17%

3.2 Future

  • Based on estimates for the next years, 1CVS will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.88% on average per year.
  • 1CVS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.08% yearly.
EPS Next Y7.26%
EPS Next 2Y10.6%
EPS Next 3Y12.01%
EPS Next 5Y10.88%
Revenue Next Year1.31%
Revenue Next 2Y2.99%
Revenue Next 3Y3.57%
Revenue Next 5Y4.08%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1CVS.MI Yearly Revenue VS Estimates1CVS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100B 200B 300B 400B 500B
1CVS.MI Yearly EPS VS Estimates1CVS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

5

4. 1CVS.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 11.80 indicates a reasonable valuation of 1CVS.
  • Based on the Price/Earnings ratio, 1CVS is valued a bit cheaper than the industry average as 73.33% of the companies are valued more expensively.
  • 1CVS is valuated cheaply when we compare the Price/Earnings ratio to 26.89, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 11.00, the valuation of 1CVS can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, 1CVS is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of 1CVS to the average of the S&P500 Index (21.97), we can say 1CVS is valued slightly cheaper.
Industry RankSector Rank
PE 11.8
Fwd PE 11
1CVS.MI Price Earnings VS Forward Price Earnings1CVS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 1CVS's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 13.07
EV/EBITDA N/A
1CVS.MI Per share data1CVS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as 1CVS's earnings are expected to grow with 12.01% in the coming years.
PEG (NY)1.63
PEG (5Y)N/A
EPS Next 2Y10.6%
EPS Next 3Y12.01%

6

5. 1CVS.MI Dividend Analysis

5.1 Amount

  • 1CVS has a Yearly Dividend Yield of 3.46%.
  • 1CVS's Dividend Yield is rather good when compared to the industry average which is at 1.64. 1CVS pays more dividend than 93.33% of the companies in the same industry.
  • 1CVS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.46%

5.2 History

  • The dividend of 1CVS has a limited annual growth rate of 5.96%.
Dividend Growth(5Y)5.96%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • 192.14% of the earnings are spent on dividend by 1CVS. This is not a sustainable payout ratio.
  • The dividend of 1CVS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP192.14%
EPS Next 2Y10.6%
EPS Next 3Y12.01%
1CVS.MI Yearly Income VS Free CF VS Dividend1CVS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B
1CVS.MI Dividend Payout.1CVS.MI Dividend Payout, showing the Payout Ratio.1CVS.MI Dividend Payout.PayoutRetained Earnings

1CVS.MI Fundamentals: All Metrics, Ratios and Statistics

CVS HEALTH CORP

BIT:1CVS (4/7/2026, 7:00:00 PM)

67.5

+0.45 (+0.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-10
Earnings (Next)05-06
Inst Owners90.77%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap86.51B
Revenue(TTM)402.07B
Net Income(TTM)1.77B
Analysts80.61
Price Target81.44 (20.65%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.46%
Yearly Dividend2.28
Dividend Growth(5Y)5.96%
DP192.14%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.24%
Min EPS beat(2)8.8%
Max EPS beat(2)15.69%
EPS beat(4)4
Avg EPS beat(4)19.56%
Min EPS beat(4)8.8%
Max EPS beat(4)30.76%
EPS beat(8)6
Avg EPS beat(8)7.29%
EPS beat(12)10
Avg EPS beat(12)6.2%
EPS beat(16)14
Avg EPS beat(16)5.76%
Revenue beat(2)2
Avg Revenue beat(2)2.03%
Min Revenue beat(2)1.02%
Max Revenue beat(2)3.04%
Revenue beat(4)4
Avg Revenue beat(4)1.93%
Min Revenue beat(4)0.02%
Max Revenue beat(4)3.64%
Revenue beat(8)5
Avg Revenue beat(8)0.75%
Revenue beat(12)9
Avg Revenue beat(12)1.31%
Revenue beat(16)13
Avg Revenue beat(16)2.17%
PT rev (1m)1.92%
PT rev (3m)0.67%
EPS NQ rev (1m)-1.3%
EPS NQ rev (3m)-1.51%
EPS NY rev (1m)-0.18%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0.29%
Revenue NQ rev (3m)-1.72%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-1.33%
Valuation
Industry RankSector Rank
PE 11.8
Fwd PE 11
P/S 0.25
P/FCF 13.07
P/OCF 9.59
P/B 1.36
P/tB N/A
EV/EBITDA N/A
EPS(TTM)5.72
EY8.47%
EPS(NY)6.14
Fwd EY9.09%
FCF(TTM)5.16
FCFY7.65%
OCF(TTM)7.04
OCFY10.42%
SpS265.93
BVpS49.75
TBVpS-23.66
PEG (NY)1.63
PEG (5Y)N/A
Graham Number80.016 (18.54%)
Profitability
Industry RankSector Rank
ROA 0.7%
ROE 2.35%
ROCE 6.3%
ROIC 4.9%
ROICexc 5.23%
ROICexgc 18.66%
OM 2.58%
PM (TTM) 0.44%
GM 13.77%
FCFM 1.94%
ROA(3y)1.95%
ROA(5y)2.24%
ROE(3y)6.46%
ROE(5y)7.21%
ROIC(3y)5.46%
ROIC(5y)6.31%
ROICexc(3y)5.85%
ROICexc(5y)6.83%
ROICexgc(3y)22.7%
ROICexgc(5y)25.24%
ROCE(3y)7.06%
ROCE(5y)8.13%
ROICexgc growth 3Y-15.72%
ROICexgc growth 5Y-3.91%
ROICexc growth 3Y-15.74%
ROICexc growth 5Y-5.12%
OM growth 3Y-19.74%
OM growth 5Y-12.87%
PM growth 3Y-30.97%
PM growth 5Y-30.29%
GM growth 3Y-6.6%
GM growth 5Y-5.48%
F-Score6
Asset Turnover1.59
Health
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 8.27
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.7%
Interest Coverage -3.47
Cash Conversion N/A
Profit Quality 441.57%
Current Ratio 0.84
Quick Ratio 0.63
Altman-Z 2.34
F-Score6
WACC8%
ROIC/WACC0.61
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.77%
Cap/Sales(5y)0.8%
Profit Quality(3y)234.42%
Profit Quality(5y)242.41%
High Growth Momentum
Growth
EPS 1Y (TTM)24.54%
EPS 3Y-8.11%
EPS 5Y-2.11%
EPS Q2Q%-8.4%
EPS Next Y7.26%
EPS Next 2Y10.6%
EPS Next 3Y12.01%
EPS Next 5Y10.88%
Revenue 1Y (TTM)7.85%
Revenue growth 3Y7.63%
Revenue growth 5Y8.39%
Sales Q2Q%8.17%
Revenue Next Year1.31%
Revenue Next 2Y2.99%
Revenue Next 3Y3.57%
Revenue Next 5Y4.08%
EBIT growth 1Y6.02%
EBIT growth 3Y-13.61%
EBIT growth 5Y-5.55%
EBIT Next Year24.76%
EBIT Next 3Y14.94%
EBIT Next 5YN/A
FCF growth 1Y23.41%
FCF growth 3Y-16.58%
FCF growth 5Y-10.28%
OCF growth 1Y16.82%
OCF growth 3Y-13.04%
OCF growth 5Y-7.68%

CVS HEALTH CORP / 1CVS.MI Fundamental Analysis FAQ

What is the fundamental rating for 1CVS stock?

ChartMill assigns a fundamental rating of 4 / 10 to 1CVS.MI.


What is the valuation status for 1CVS stock?

ChartMill assigns a valuation rating of 5 / 10 to CVS HEALTH CORP (1CVS.MI). This can be considered as Fairly Valued.


How profitable is CVS HEALTH CORP (1CVS.MI) stock?

CVS HEALTH CORP (1CVS.MI) has a profitability rating of 2 / 10.


What is the financial health of CVS HEALTH CORP (1CVS.MI) stock?

The financial health rating of CVS HEALTH CORP (1CVS.MI) is 3 / 10.


What is the earnings growth outlook for CVS HEALTH CORP?

The Earnings per Share (EPS) of CVS HEALTH CORP (1CVS.MI) is expected to grow by 7.26% in the next year.